HeartSciences (HSCS) Share-based Compensation (2021 - 2026)

HeartSciences has reported Share-based Compensation for 6 years, with the latest figure at -$503107.0 in Q1 2026.

• For the quarter ending Q1 2026, Share-based Compensation changed N/A year-over-year to -$503107.0; the trailing twelve-month figure through Jan 2026 stood at $268926.0 (up 203.9% YoY), and the FY2025 full-year result was $170637.0, down 57.87% from the prior year.
• Share-based Compensation for Q1 2026 stood at -$503107.0, down from $436884.0 in the prior quarter.
• The five-year high for Share-based Compensation was $436884.0 in Q4 2025, with the low at -$503107.0 in Q1 2026.
• Historically, Share-based Compensation has averaged $66552.2 across 5 years, with a median of $99154.0 in 2023.
• Annual changes were most pronounced in 2022 — Share-based Compensation jumped 8956.68% — and 2023, when it slumped 98.69%.
• HeartSciences' Share-based Compensation stood at $1918.0 in 2022, then soared by 5418.25% to $105840.0 in 2023, then plunged by 90.51% to $10046.0 in 2024, then surged by 4248.84% to $436884.0 in 2025, then plunged by 215.16% to -$503107.0 in 2026.
• The last three Share-based Compensation figures came in at -$503107.0 (Q1 2026), $436884.0 (Q4 2025), and $174558.0 (Q3 2025), per Business Quant data.